{"id":"W2727639121","doi":"10.1093/annonc/mdx302.009","title":"Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; FOLFOX; Oncology; CD8; Colorectal cancer; Stage (stratigraphy); Immune system; Gastroenterology; Cancer; Immunology; Oxaliplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005579317,0.0001565607,0.001004462,0.0001502115,0.0000374527,0.000004047542,0.0001255313,0.0001431874,0.00004247195],"category_scores_gemma":[0.0003885637,0.0001264206,0.00008712852,0.0001449827,0.000385981,0.0001090435,0.0000786021,0.0001580171,2.454181e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000372016,"about_ca_system_score_gemma":0.0002573678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003197163,"about_ca_topic_score_gemma":0.0008627885,"domain_scores_codex":[0.9983793,0.0001448073,0.0008033226,0.0002528302,0.0001888005,0.0002309163],"domain_scores_gemma":[0.9983568,0.0001527627,0.0008196837,0.000309419,0.0002961978,0.00006520256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2031586,0.002724624,0.773159,0.0002174031,0.00006464992,0.00007847738,0.0006384825,8.140506e-7,0.00612734,0.000008684969,0.00002247976,0.01379948],"study_design_scores_gemma":[0.1029648,0.02821256,0.845318,0.0002608329,0.0000817075,0.000003284936,0.0002104091,0.0001840332,0.02261123,0.0000190876,0.00004671893,0.00008729147],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970089,0.000324263,8.730956e-7,0.0002177416,0.000054247,0.001440387,0.0000535146,0.00000453957,0.000895522],"genre_scores_gemma":[0.9996279,0.0001138377,0.00002128244,0.00001966187,0.00001353201,0.000045277,0.00007714632,0.000009838983,0.0000715366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1001938,"threshold_uncertainty_score":0.5155284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06638419118006342,"score_gpt":0.360245104695067,"score_spread":0.2938609135150037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}